Hasylated polypeptides

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8618266
APP PUB NO 20060019877A1
SERIAL NO

11078582

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to hydroxyalkylstarch (HAS)-polypeptide-conjugate (HAS-polypeptide) comprising one or more HAS molecules, wherein each HAS is conjugated to the polypeptide via a carbohydrate moiety or a thioether as well as to methods for the production thereof. In a preferred embodiment, the polypeptide is erythropoietin (EPO).

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
FRESENIUS KABI DEUTSCHLAND GMBHELSE-KRONER-STRASSE 1 BAD HOMBURG 61352

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Conradt, Harald S Braunschweig, DE 4 93
Eichner, Wolfram Butzbach, DE 32 545
Frank, Ronald Meine Grassel, DE 31 520
Grabenhorst, Eckart Braunschweig, DE 2 44
Nimtz, Manfred Wolfenbüttel, DE 1 33
Zander, Norbert Meine, DE 44 345

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 30, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00